NGS use is validated in 2025 American Urological Association guideline update, marking an important step towards more accurate and rapid urinary infection diagnostics. ORLANDO, FL / ACCESS Newswire / ...
The global systemic mastocytosis market is witnessing robust growth, driven by increased prevalence of KIT gene mutations and advancements in targeted therapies like avapritinib and bezuclastinib.
Companion diagnostics (CDx), once considered niche in oncology, are now emerging as a cornerstone of precision medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback